A new bill in the U.S. Senate proposes to regulate selective androgen receptor modulators (SARMs) by placing the compounds in the same category as anabolic steroids. Sens. Chuck Grassley (R-Iowa) and Sheldon Whitehouse (D-Rhode Island) introduced legislation (S.2895) that would amend the Controlled Substances Act (CSA) to add SARMs to the list of Schedule III...Read More